Aerie Pharmaceuticals Inc Asset Turnover Ratio (AERI), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aerie Pharmaceuticals Inc   (NASDAQ: AERI)
 

Aerie Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aerie Pharmaceuticals Inc asset turnover ratio, the ability of Aerie Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2022, increased sequentially to 0.57 in the third quarter (Sep 30 2022), AERI's balance sheet remain strong.

Within sector 15 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2022, to 2145, from total ranking in the second quarter 2022 at 2157.

Asset Turnover Ratio Definition



AERI Asset Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Asset Change 8.03 % 6.26 % 7.52 % 5.43 % -6.22 %
Y / Y Revenue Change 23.25 % 22.53 % 29.89 % 364.55 % 45.97 %
Asset Turnover Ratio (TTM) 0.57 0.56 0.55 0.54 0.29
AERI's Total Ranking # 2145 # 2157 # 2139 # 2344 # 2766
Seq. Asset Change -2.5 % -2.91 % -8.28 % 24.42 % -4.1 %
Seq. Revenue Change 8.46 % 11.65 % -73.98 % 291.18 % 7.83 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 258
Overall Market # 2145

Asset Turnover Ratio Statistics
High Average Low
0.54 0.29 0.12
(Sep 30 2022)   (Mar 31 2019)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Champions Oncology Inc   1.62 $ 54.096  Millions$ 33.431  Millions
Chemed Corporation  1.61 $ 2,139.657  Millions$ 1,329.410  Millions
Progyny Inc   1.60 $ 700.145  Millions$ 436.727  Millions
Cadre Holdings inc   1.56 $ 437.729  Millions$ 281.463  Millions
Encision Inc   1.52 $ 7.406  Millions$ 4.879  Millions
Prophase Labs Inc   1.52 $ 145.980  Millions$ 96.196  Millions
Vaso Corporation  1.50 $ 81.046  Millions$ 54.043  Millions
Henry Schein Inc   1.49 $ 12,606.522  Millions$ 8,446.523  Millions
Biomerica Inc   1.49 $ 19.247  Millions$ 12.951  Millions
Sunlink Health Systems Inc   1.48 $ 42.656  Millions$ 28.727  Millions
Mimedx Group Inc   1.48 $ 260.875  Millions$ 175.959  Millions
International Stem Cell Corporation  1.45 $ 7.593  Millions$ 5.226  Millions
Skinhealth Systems Inc   1.42 $ 393.089  Millions$ 276.199  Millions
Agilon Health Inc   1.39 $ 2,481.323  Millions$ 1,788.105  Millions
Lftd Partners Inc   1.37 $ 58.890  Millions$ 42.842  Millions
Docgo Inc   1.37 $ 453.055  Millions$ 330.644  Millions
Rockwell Medical inc   1.32 $ 65.718  Millions$ 49.828  Millions
Vycor Medical Inc   1.31 $ 1.225  Millions$ 0.932  Millions
Option Care Health Inc   1.31 $ 3,844.716  Millions$ 2,932.092  Millions
Idexx Laboratories Inc  1.30 $ 3,339.846  Millions$ 2,569.286  Millions
Bionexus Gene Lab Corp   1.30 $ 11.334  Millions$ 8.729  Millions
Procyon Corporation  1.27 $ 4.828  Millions$ 3.803  Millions
Innovage Holding Corp   1.25 $ 696.788  Millions$ 557.630  Millions
Wearable Health Solutions, Inc.  1.25 $ 0.960  Millions$ 0.771  Millions
Psychemedics Corporation  1.24 $ 25.973  Millions$ 20.862  Millions
Sunwin Stevia International Inc.  1.22 $ 33.998  Millions$ 27.835  Millions
Embecta Corp   1.22 $ 1,129.500  Millions$ 927.400  Millions
Interpace Biosciences Inc   1.22 $ 38.771  Millions$ 31.892  Millions
Dynatronics Corporation  1.21 $ 44.091  Millions$ 36.398  Millions
Zynex inc   1.20 $ 149.729  Millions$ 125.081  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.